The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Naloxone Protects Rat Dopaminergic Neurons against Inflammatory Damage through Inhibition of Microglia Activation and Superoxide Generation
Abstract
Degeneration of dopaminergicrgic neurons in the substantia nigra of the brain is a hallmark of Parkinson's disease and inflammation and oxidative stress are closely associated with the pathogenesis of degenerative neurological disorders. Treatment of rat mesencephalic mixed neuron-glia cultures with lipopolysaccharide (LPS)-activated microglia, resident immune cells of the brain, to release proinflammatory and neurotoxic factors tumor necrosis factor-alpha, interleukin-1beta, nitric oxide, and superoxide and subsequently caused damage to midbrain neurons, including dopaminergic neurons. The LPS-induced degeneration of the midbrain neurons was significantly reduced by cotreatment with naloxone, an opioid receptor antagonist. This study focused on understanding the mechanism of action for the protective effect of naloxone on dopaminergic neurons because of relevance to Parkinson's disease. Both naloxone and its opioid receptor inactive stereoisomer (+)-naloxone protected the dopaminergic neurons with equal potency. Naloxone inhibited LPS-induced activation of microglia and release of proinflammatory factors, and inhibition of microglia generation of superoxide free radical best correlated with the neuroprotective effect of naloxone isomers. To further delineate the site of action, naloxone was found to partially inhibit the binding of [(3)H]LPS to cell membranes, whereas it failed to prevent damage to dopaminergic neurons by peroxynitrite, a product of nitric oxide and superoxide. These results suggest that naloxone at least in part interferes with the binding of LPS to cell membranes to inhibit microglia activation and protect dopaminergic neurons as well as other neurons in the midbrain cultures from inflammatory damage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alternative drugs with anti-inflammatory properties, including dexamethasone, minocycline, naloxone, are going to be or have already been tested in preclinical and clinical trials.560–562”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [562]
Citations
Cites
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
Green, L. C., Wagner, D. A., Glogowski, J. A., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90118-x · Cited by 12,061
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Phylogenetic Perspectives in Innate Immunity
Hoffmann, J. A., Kafatos, F. C., Janeway, C. A., & Ezekowitz, R. A. B. (1999) · Science · doi:10.1126/science.284.5418.1313 · Cited by 2,524
MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287 · cited 1×
“It is well accepted that proinflammatory and cytotoxic factors produced by activated microglia contribute to neurodegeneration and that prevention of microglia activation serves to reduce neuronal injury (McGeer and McGeer, 1995; Epstein, 1998).”
Activated microglia mediate neuronal cell injury via a nitric oxide mechanism
Chao, C. C., Hu, S., Molitor, T. W., Shaskan, E. G., & Peterson, P. K. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.8.2736 · Cited by 1,138
Banati, R. B., Gehrmann, J., Schubert, P., & Kreutzberg, G. W. (1993) · Glia · doi:10.1002/glia.440070117 · Cited by 1,032
Oxidative stress and the pathogenesis of Parkinson's disease
Jenner, P., & Olanow, C. W. (1996) · Neurology · doi:10.1212/wnl.47.6_suppl_3.161s · Cited by 971
Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death
Boje, K. M., & Arora, P. K. (1992) · Brain Research · doi:10.1016/0006-8993(92)91004-x · Cited by 944
Beckman, J. S., Carson, M. A., Smith, C. D. L., & Koppenol, W. H. (1993) · Nature · doi:10.1038/364584a0 · Cited by 876
Dickson, D. W., Lee, S. C., Mattiace, L. A., Yen, S.-H. C., & Brosnan, C. F. (1993) · Glia · doi:10.1002/glia.440070113 · Cited by 821
The microestimation of succinate and the extinction coefficient of cytochrome c
Massey, V. (1959) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(59)90259-8 · Cited by 752
[41] Preparation and assay of superioxide dismutases
Crapo, J. D., McCord, J. M., & Fridovich, I. (1978) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(78)53044-9 · Cited by 686
Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide
Minghetti, L. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00052-x · Cited by 562
Dawson, V. L., Dawson, T. M., Uhl, G. R., & Snyder, S. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3256 · Cited by 345
Glutathione Regulation of Neutral Sphingomyelinase in Tumor Necrosis Factor-α-induced Cell Death
Liu, B., Andrieu‐Abadie, N., Levade, T., Zhang, P., Obeid, L. M., & Hannun, Y. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.11313 · Cited by 337
Self-citationMolecular biology and pharmacology of cloned opioid receptors 1
Knapp, R. J., Malatyńska, E., Collins, N., Fang, L., Wang, J. Y., Hruby, V. J., Roeske, W. R., & Yamamura, H. I. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.7.7737460 · Cited by 235
Pharmacological strategies in CNS trauma
Faden, A. I., & Salzman, S. K. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90013-v · Cited by 230
Reversal of Induced Ischemic Neurologic Deficit in Gerbils by the Opiate Antagonist Naloxone
Hosobuchi, Y., Baskin, D. S., & Woo, S. K. (1982) · Science · doi:10.1126/science.6274019 · Cited by 202
Merrill, J. E., Koyanagi, Y., Zack, J. A., Thomas, L. L., Martin, F. C., & Chen, I. S. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2217-2225.1992 · Cited by 198
Multiple Sclerosis: Immune System Molecule Expression in the Central Nervous System
Raine, C. S. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199407000-00002 · Cited by 195
Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures
Bronstein, D. M., Pérez‐Otaño, I., Sun, V., Sawin, S. B. M., Chan, J., Wu, G.-C., Hudson, P. M., Kong, L., Hong, J., & McMillian, M. (1995) · Brain Research · doi:10.1016/0006-8993(95)01189-7 · Cited by 186
Self-citationJeohn, G., Kong, L., Wilson, B. C., Hudson, P. M., & Hong, J. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00204-x · Cited by 183
Self-citationEGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture
Casper, D., Mytilineou, C., & Blum, M. (1991) · Journal of Neuroscience Research · doi:10.1002/jnr.490300213 · Cited by 172
β-Amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity
Ii, M., Sunamoto, M., Ohnishi, K., & Ichimori, Y. (1996) · Brain Research · doi:10.1016/0006-8993(96)00156-4 · Cited by 163
Studies in the (+)-morphinan series. 5. Synthesis and biological properties of (+)-naloxone
Iijima, I., Minamikawa, J., Jacobson, A. E., Brossi, A. R., Rice, K. C., & Klee, W. A. (1978) · Journal of Medicinal Chemistry · doi:10.1021/jm00202a018 · Cited by 152
Goodwin, D. C., Gunther, M. R., Hsi, L. C., Crews, B. C., Eling, T. E., Mason, R. P., & Marnett, L. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.8903 · Cited by 125
Inflammation in the CNS: balance between immunological privilege and immune responses
Matyszak, M. K. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00014-8 · Cited by 118
Chao, C. C., Gekker, G., Sheng, W., Hu, S., Tsang, M., & Peterson, P. K. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38683-0 · Cited by 101
A double blind trial of naloxone in the treatment of acute stroke.
Fallis, R. J., Fisher, M., & Løbo, R. A. (1984) · Stroke · doi:10.1161/01.str.15.4.627 · Cited by 71
Kong, L., McMillian, M., Hudson, P. M., Jin, L., & Hong, J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36393-1 · Cited by 66
Self-citationNaloxone inhibits superoxide release from human neutrophils
Simpkins, C., Ives, N., Tate, E. A., & Johnson, M. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90076-1 · Cited by 45
Das, K. P., McMillian, M., Bing, G., & Hong, J. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00083-e · Cited by 44
Self-citationThe toxicity of MPTP to dopamine neurons in culture is reduced at high concentrations
Friedman, L. K., & Mytilineou, C. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90673-2 · Cited by 36
Endogenous Opioids Regulate the Expression of Inducible Nitric Oxide Synthase by Splenocytes
Lysle, D. T., & How, T. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37982-0 · Cited by 35
High concentrations of naloxone attenuate N-methyl-D-aspartate receptor-mediated neurotoxicity
Kim, J. P., Goldberg, M. P., & Choi, D. W. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90349-9 · Cited by 33
HIV neuropathogenesis and therapeutic strategies
Epstein, L. G. (1998) · Pediatrics International · doi:10.1111/j.1442-200x.1998.tb01892.x · Cited by 23
Dunwiddie, T. V., Perez‐Reyes, E., Rice, K. C., & Palmer, M. R. (1982) · Neuroscience · doi:10.1016/0306-4522(82)90027-6 · Cited by 22
A stereoselective blockade by naloxone of opioid and non-opioid-induced granulocyte activation
Marcoli, M., Ricevuti, G., Mazzone, A., Pasotti, D., Lecchini, S., & Frigo, G. M. (1989) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(89)90099-4 · Cited by 22
Prevention of cocaine-induced hyperactivity by a naloxone isomer with no opiate antagonist activity
Chatterjie, N., Alexander, G. J., SECHZER, J. A., & Lieberman, K. W. (1996) · Neurochemical Research · doi:10.1007/bf02527726 · Cited by 21
Compston, A. (1993) · Molecular and Chemical Neuropathology · doi:10.1007/bf03160168 · Cited by 16
Kan, M.-N., Chen, Y.-T., & Lee, A. Y. (1992) · Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine · doi:10.3181/00379727-200-43464 · Cited by 16
Dextro-Naloxone Counteracts Amphetamine-Induced Hyperactivity
Chatterjie, N. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00528-5 · Cited by 16
Cited by
Sorted by citations
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616
“Naloxone has been shown to safeguard dopaminergic neurons by impeding microglial activation and the production of pro-inflammatory cytokines.(477) Similarly, celecoxib protects dopaminergic neurons from degeneration by suppressing microglial activation via inhibiting COX-2 in a rat model of PD.”
BackgroundLiu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
“First, neurodegeneration induced by a single bolus application of microgram levels of LPS occurred within a few days (Castano et al., 1998; Liu et al., 2000d; Lu et al., 2000; Iravani et al., 2002).”
BackgroundInfluentialSelf-citationNeuroinflammation in Parkinson's disease and its potential as therapeutic target
Wang, Q., Liu, Y., & Zhou, J. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0042-0 · Cited by 884
“The compound dramatically reverses the acute dystonia and parkinsonism following general anaesthesia [115, 116].”
BackgroundKim, W., Mohney, R. P., Wilson, B. C., Jeohn, G., Liu, B., & Hong, J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06309.2000 · Cited by 881
“Enriched microglia were prepared following a previously described protocol (Liu et al., 2000a).”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Liu, B., Du, L., & Hong, J.-S.
- Affiliations
- National Institutes of Health (US)
- National Institute of Environmental Health Sciences (US)
- Corresponding author
- Liu, Bin
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2000-04
- Volume
- 293
- Issue
- 2
- Pages
- 607-617
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W1891696008
- Cited by
- 347
- References
- 43
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 4 · 2023: 11 · 2022: 11 · 2021: 10 · 2020: 5 · 2019: 2 · 2018: 7 · 2017: 12 · 2016: 10 · 2015: 16 · 2014: 11 · 2013: 13 · 2012: 26
- FWCI
- 8.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- naloxone, dopaminergic neurons, Parkinson's disease, microglial activation, lipopolysaccharide, neuroinflammation, oxidative stress, superoxide, neuroprotection, substantia nigra, opioid antagonists, peroxynitrite, nitric oxide, inflammatory cytokines
- MeSH terms
- Animals, Cells, Cultured, Dopamine, Immunohistochemistry, Inflammation, Interleukin-1, Lipopolysaccharides, Mesencephalon, Naloxone, Narcotic Antagonists, Neurons, Nitrates, Nitrites, Rats, Inbred F344, Stereoisomerism, Substantia Nigra, Superoxides, Tumor Necrosis Factor-alpha, Tyrosine 3-Monooxygenase, Oxidants, Microglia, Mitogen-Activated Protein Kinases, Mitogen-Activated Protein Kinase 3, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
